• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(±)-和(-)-125碘氰吲哚洛尔对完整人淋巴细胞中β2肾上腺素能受体的结合特性相同。

Identical binding properties of (+/-)- and (-)-125Iodocyanopindolol to beta 2-adrenoceptors in intact human lymphocytes.

作者信息

O'Hara N, Brodde O E

出版信息

Arch Int Pharmacodyn Ther. 1984 Nov;272(1):24-39.

PMID:6097199
Abstract

In intact human lymphocytes the properties of (+/-)- and (-)-125iodocyanopindolol (ICYP) binding to beta 2-adrenoceptors were investigated. Binding of both ligands was in concentrations ranging from 10-200 pM saturable resulting in identical Bmax-values (about 550-650 specific ICYP binding sites/cell); the KD-value of (-)-ICYP (14.8 +/- 0.1 pM, N = 3), however, was about two times lower than that of (+/-)-ICYP (26.5 +/- 2.5 pM, N = 3). Irrespective of the ligand used alprenolol, betaxolol, ICI 118,551 and isoprenaline inhibited binding with identical KI-values. Binding was stereospecific, since the (+)-isomers of alprenolol and isoprenaline were about 50 times less potent in inhibiting binding than their respective (-)-isomers. In concentrations greater than 250 pM both ligands labeled a second class of binding sites in a non-saturable manner. These low affinity sites showed no stereospecificity; they may be related to unspecific uptake of the ligands into the cell. In kinetic experiments biphasic dissociation reactions were obtained for (+/-)- as well as (-)-ICYP; for both ligands the ratio fast/slow dissociating component was 40/60. It is concluded, that at low receptor concentrations (2.5-5 pmoles/l in the present study) the contribution of the (+)-isomer of ICYP to binding of the racemic ligand can be neglected. Thus, at low receptor concentrations both (+/-) and (-)-ICYP exhibit identical binding properties to beta 2-adrenoceptors in intact human lymphocytes.

摘要

研究了在完整人淋巴细胞中(±)-和(-)-125碘氰吲哚洛尔(ICYP)与β2-肾上腺素能受体结合的特性。两种配体的结合在10-200 pM的浓度范围内是可饱和的,产生相同的Bmax值(约550-650个特异性ICYP结合位点/细胞);然而,(-)-ICYP的KD值(14.8±0.1 pM,N = 3)比(±)-ICYP的KD值(26.5±2.5 pM,N = 3)低约两倍。无论使用何种配体,阿普洛尔、倍他洛尔、ICI 118,551和异丙肾上腺素都以相同的KI值抑制结合。结合具有立体特异性,因为阿普洛尔和异丙肾上腺素的(+)-异构体在抑制结合方面的效力比其各自的(-)-异构体低约50倍。在浓度大于250 pM时,两种配体都以非饱和方式标记了第二类结合位点。这些低亲和力位点没有立体特异性;它们可能与配体非特异性摄取到细胞中有关。在动力学实验中,(±)-和(-)-ICYP都获得了双相解离反应;对于两种配体,快速/缓慢解离成分的比例均为40/60。得出的结论是,在低受体浓度下(本研究中为2.5-5 pmoles/l),ICYP的(+)-异构体对消旋配体结合的贡献可以忽略不计。因此,在低受体浓度下,(±)-和(-)-ICYP在完整人淋巴细胞中对β2-肾上腺素能受体表现出相同的结合特性。

相似文献

1
Identical binding properties of (+/-)- and (-)-125Iodocyanopindolol to beta 2-adrenoceptors in intact human lymphocytes.(±)-和(-)-125碘氰吲哚洛尔对完整人淋巴细胞中β2肾上腺素能受体的结合特性相同。
Arch Int Pharmacodyn Ther. 1984 Nov;272(1):24-39.
2
Demonstration of beta 1-adrenergic receptors in human placenta by (-)[125I]iodocyanopindolol binding.通过(-)[125I]碘氰吲哚洛尔结合法证明人胎盘中的β1-肾上腺素能受体。
J Nucl Med Allied Sci. 1989 Jan-Mar;33(1):15-21.
3
Identification and characterisation of beta-adrenoceptors on intact equine peripheral blood lymphocytes with the radioligand (-)-[125I]-iodocyanopindolol.用放射性配体(-)-[¹²⁵I]-碘氰吲哚洛尔对完整马外周血淋巴细胞上的β-肾上腺素能受体进行鉴定和表征。
Equine Vet J. 2001 Sep;33(5):487-93. doi: 10.2746/042516401776254862.
4
Receptors for beta-adrenergic agonists in cultured chick ventricular cells. Relationship between agonist binding and physiologic effect.培养的鸡心室细胞中β-肾上腺素能激动剂的受体。激动剂结合与生理效应之间的关系。
Mol Pharmacol. 1985 Jan;27(1):10-8.
5
Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts.心肌膜制剂中125I-碘氰吲哚洛尔的特异性非β-肾上腺素能结合位点:人、大鼠和猪心脏的比较研究。
Cardiovasc Res. 1991 Sep;25(9):764-73. doi: 10.1093/cvr/25.9.764.
6
Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes.棕色脂肪组织和骨骼肌膜中假定的β3-肾上腺素能受体的配体结合特性比较
Br J Pharmacol. 1993 Aug;109(4):1157-63. doi: 10.1111/j.1476-5381.1993.tb13743.x.
7
Receptor-independent sequestration of beta-adrenergic ligands by alveolar type II cells.肺泡II型细胞对β-肾上腺素能配体的非受体依赖性隔离
Am J Physiol. 1986 Jun;250(6 Pt 1):C871-9. doi: 10.1152/ajpcell.1986.250.6.C871.
8
Binding of 125I-cyanopindolol to beta-1-adrenoceptors in a high and low affinity state.125I-氰基吲哚洛尔与处于高亲和力和低亲和力状态的β-1肾上腺素能受体的结合
J Recept Res. 1983;3(1-2):45-59. doi: 10.3109/10799898309041922.
9
Identification of a homogeneous class of beta 2-adrenoceptors in human platelets by (-)-125I-iodopindolol binding.通过(-)-125I-碘吲哚洛尔结合鉴定人血小板中一类同质的β2-肾上腺素能受体。
J Cyclic Nucleotide Protein Phosphor Res. 1985;10(5):439-50.
10
Application of [125I]iodocyanopindolol to measure 5-hydroxytryptamine1B receptors in the brain of the rat.应用[125I]碘氰吲哚洛尔测定大鼠脑中5-羟色胺1B受体。
J Pharmacol Exp Ther. 1988 Jan;244(1):144-53.

引用本文的文献

1
Hydrolysis of haloperidol decanoate in vitro by cultured cells.培养细胞对癸酸氟哌啶醇的体外水解作用。
Eur J Drug Metab Pharmacokinet. 1987 Jul-Sep;12(3):183-8. doi: 10.1007/BF03189895.
2
Up-regulation of beta-adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjects.在正常受试者中,可乐定降低中枢交感神经传出后,循环单核细胞上β-肾上腺素能受体上调。
Clin Auton Res. 1992 Jun;2(3):165-70. doi: 10.1007/BF01818957.